Update on Childhood Asthma: Agents and Actions Supplements, cartea 40
Autor M.H. Schöni, Kraemeren Limba Engleză Paperback – 16 noi 2012
Din seria Agents and Actions Supplements
- Preț: 388.88 lei
- Preț: 376.34 lei
- Preț: 373.92 lei
- Preț: 371.11 lei
- Preț: 372.07 lei
- Preț: 377.45 lei
- Preț: 388.29 lei
- Preț: 381.41 lei
- Preț: 376.72 lei
- Preț: 370.58 lei
- Preț: 373.18 lei
- Preț: 379.51 lei
- Preț: 379.72 lei
- Preț: 377.45 lei
- Preț: 388.88 lei
- Preț: 385.71 lei
- 5% Preț: 382.38 lei
- Preț: 378.99 lei
- Preț: 377.09 lei
- Preț: 381.20 lei
- 5% Preț: 700.55 lei
- 5% Preț: 354.17 lei
- 5% Preț: 356.48 lei
- Preț: 368.32 lei
- 5% Preț: 350.09 lei
- 5% Preț: 357.72 lei
Preț: 375.61 lei
Nou
Puncte Express: 563
Preț estimativ în valută:
71.88€ • 75.60$ • 60.06£
71.88€ • 75.60$ • 60.06£
Carte tipărită la comandă
Livrare economică 08-22 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783034873871
ISBN-10: 3034873875
Pagini: 236
Ilustrații: VIII, 223 p. 41 illus.
Dimensiuni: 170 x 244 x 12 mm
Greutate: 0.38 kg
Ediția:Softcover reprint of the original 1st ed. 1993
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Agents and Actions Supplements
Locul publicării:Basel, Switzerland
ISBN-10: 3034873875
Pagini: 236
Ilustrații: VIII, 223 p. 41 illus.
Dimensiuni: 170 x 244 x 12 mm
Greutate: 0.38 kg
Ediția:Softcover reprint of the original 1st ed. 1993
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Agents and Actions Supplements
Locul publicării:Basel, Switzerland
Public țintă
ResearchCuprins
Etiology of Childhood Asthma.- Consequences of unbalanced protease in the lung: Protease involvement in destruction and local defense mechanisms of the lung.- The “wheezy infant” — Diagnosis, epidemiology and management.- Psychosomatic symptoms in asthmatic children and adolescents.- Pulmonary Function Testing in Childhood.- Assessment of functional abnormalities in infants and children with lung disease.- A new method for assessing flow-volume measurements by means of a simple isoflow electronic pocket device (IfloPen™).- The interruptor technique — A renaissance of a non-invasive approach for lung function testing in infants and children.- The lung clearance index (LCI) as an estimate of ventilation inequalities in patients with cystic fibrosis.- Epidemiology of Childhood Asthma.- Prevalence of childhood asthma: Facts, tendencies and interpretations.- Changing pattern of asthmatic symptoms during childhood — different diseases?.- Immunology and Airway Inflammation in Childhood Asthma.- Airway inflammation, bronchial reactivity and asthma.- A specific feedback by anti-IgE autoantibodies on the cytokine network in allergy.- Immuno-allergologic aspects of childhood asthma.- Prevention and Prophylaxis of Allergies and Asthma.- Mechanisms of airway inflammation which may be amenable to prophylaxis.- The risks and benefits of inhaled antiinflammatory therapy in children.- Treatment of Childhood Asthma.- The beta-2-agonist perplexity: pro and contra sympathometic drugs in childhood asthma.- The use of inhaled steroids in young children.- Comparison of different inhalation scheduls to control childhood asthma.